Richard Klausner, Director at Juno Therapeutics, Inc. (JUNO), sold 24,000 shares at $42.79 ($1.0M) on 2016-04-15, disclosed to the SEC on 2016-04-19.
Open-market sale of $1.0M JUNO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.79 | 10,007 | $428K | 41.6% |
| 2 | $42.79 | 10,007 | $428K | 41.6% |
| 3 | $43.51 | 1,993 | $87K | 8.4% |
| 4 | $43.51 | 1,993 | $87K | 8.4% |
| Total | $42.91 avg | 24,000 | $1.0M | 100% |
| Filing → |
| LYEL | SELL | 2022-09-27 | $71K | — | Filing → |
| JUNO | SELL | 2018-01-09 | $1.2M | — | Filing → |
| JUNO | SELL | 2017-12-22 | $3.2M | — | Filing → |